Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Hereditary Cancer Panel Comprehensive Molecular Genetics Laboratory London Health Sciences Centre Canada | 39 | 30 |
|
Severe Combined Immunodeficiency Panel Mayo Clinic Laboratories Mayo Clinic United States | 61 | 63 |
|
Hereditary Cancer Panel - High Penetrance 16 Molecular Genetics Laboratory London Health Sciences Centre Canada | 28 | 16 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics United States | 94 | 55 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene US, LLC - The Rare Disease Company United States | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene US, LLC - The Rare Disease Company United States | 442 | 443 |
|
Bone Marrow Failure / Anemia Panel Centogene US, LLC - The Rare Disease Company United States | 212 | 212 |
|
Centogene US, LLC - The Rare Disease Company United States | 289 | 275 |
|
Centogene US, LLC - The Rare Disease Company United States | 669 | 688 |
|
Centogene US, LLC - The Rare Disease Company United States | 323 | 329 |
|
Centogene US, LLC - The Rare Disease Company United States | 27 | 29 |
|
Centogene US, LLC - The Rare Disease Company United States | 1886 | 1858 |
|
Centogene US, LLC - The Rare Disease Company United States | 734 | 744 |
|
ATM - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 2 | 1 |
|
Centogene US, LLC - The Rare Disease Company United States | 2 | 1 |
|
Centogene US, LLC - The Rare Disease Company United States | 58 | 28 |
|
Centogene US, LLC - The Rare Disease Company United States | 67 | 33 |
|
Centogene US, LLC - The Rare Disease Company United States | 114 | 68 |
|
Centogene US, LLC - The Rare Disease Company United States | 156 | 107 |
|
Centogene US, LLC - The Rare Disease Company United States | 218 | 135 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.